NEW YORK (GenomeWeb) – IncellDx today announced a worldwide exclusive licensing and supply agreement to couple the firm's reagents with Claremont BioSolutions' enzyme-free tissue homogenization technology.

The combination sample prep system will be called IncellPrep Liquid Biopsy and will prepare cell suspensions from either fresh or FFPE tissues for molecular diagnostics by flow or image cytometry.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.

Sponsored by

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.